logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
6/10/2019 6:58:51 AM Merck To Acquire Tilos Therapeutics For Potential Consideration Of $773 Mln
6/2/2019 9:16:51 AM AstraZeneca And Merck Announce Detailed Results From Phase 3 POLO Trial Of LYNPARZA Tablets
5/28/2019 4:20:26 PM Merck & Co Inc. (MRK) Declares $ 0.55 Dividend for Q3 19, Record Date 6/17/2019
5/21/2019 7:02:19 AM Merck To Acquire Privately Held Peloton Therapeutics
5/7/2019 6:54:26 AM Merck Says BELSOMRA C-IV Meets Primary Efficacy Endpoint In Phase 3 Trial
4/30/2019 6:49:03 AM Merck Q1 GAAP EPS $1.12; Non-GAAP EPS $1.22
4/22/2019 6:49:51 AM Merck Says FDA Approved KEYTRUDA In Combination With Inlyta
4/4/2019 7:09:37 AM Myriad, AstraZeneca And Merck Expand Companion Diagnostic Partnership
4/2/2019 6:52:48 AM Merck Completes Tender Offer To Buy Immune Design